Skip to main content
All lobbying filings

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Lobbying for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $140,000.00 expenses · posted Oct 23, 2025

Official filing document

 Bills named in this filing 10
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 3521
    Clinical Trial Modernization Act
  • HR 2571
    Self-Insurance Protection Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
  • HR 247
    Health Care Affordability Act of 2025
  • HR 4317
    PBM Reform Act of 2025
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • HR 801
    Charitable Act
 Lobbying activity 4
Health Issues

HR 1262 / S 932, Give Kids a Chance Act; HR 3521, Clinical Trial Modernization Act; HR 2571, Self-insurance Protection Act; HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 247 / S 46, Health Care Affordability Act; HR 4317, PBM Reform Act; S 2420, No Surprises Act Enforcement Act; HR 5371, Continuing Appropriations and Extensions Act, 2026, specifically proposals to include an extension of the enhanced Advanced Premium Tax Credits

Medicare/Medicaid

HR 1, To provide for reconciliation pursuant to title II of H Con Res 14; HR 1509 / S 752, Accelerating Kids Access to Care Act (AKACA); S 2497, Fair Billing Act; S 1629, Same Care, Lower Cost Act;

Taxation/Internal Revenue Code

HR 1, To provide for reconciliation pursuant to title II of H Con Res 14, specifically provisions to expand the charitable giving tax deduction to non-itemizers; HR 801 / S 317, the Charitable Act;

Budget/Appropriations

HR 5371, Continuing Appropriations and Extensions Act, 2026, specifically provisions related to medical research funding;

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem